KLLN and PTEN hamartoma tumor syndrome: As KLLN was described as a possible phenotype modifier [15], we explored its role in our PHTS patients and found an overexpression of KLLN that correlated with an overexpression of PTEN (which may indicate a co-regulation of these genes due to their shared bidirectional promoter).